A service of

Continuation vehicle surge reflects private equity’s USD 5tn challenge – Dealspeak North America

  • Announced CV deal count surges 52% year-on-year
  • Unsold PE assets reach USD 4tn-USD 5tn
  • GP-led secondaries sees increased specialization

Continuation vehicle (CV) deal activity is surging as sponsors across the size spectrum turn to the GP-led secondaries market.

Year-to-date, Mergermarket has tracked 50 announced CVs from North American-based GPs, a 52% year-on-year increase. Many transactions aren’t disclosed, meaning activity levels market-wide are higher.

Evercore estimates that GP-led secondary volume reached USD 65bn in 1H26, up 35% year-on-year. Single-asset CVs accounted for around 56% of that deal flow.

The rise in CV transactions is partly a function of a challenging liquidity backdrop. As Mergermarket has reported, while exits neared record highs in 2025 and 2026 by dollar volume and deal count, buyouts have expanded more dramatically.

The result is a market environment where inventory has tripled, but liquidity has remained relatively flat, Andrew DiGeronimo, a managing director and co-head of partnership solutions at Warburg Pincus, recently told Mergermarket. There are now around 35,000 unsold private equity-backed companies worth approximately USD 4tn-USD 5tn, he estimated.

Many conclude that CVs have risen in prominence simply as a pressure-release valve.

Yet that only tells part of the story. As private equity hold periods elongate – the average is now 6.25 years at exit, according to Mergermarket data – and traditional exit routes struggle to keep pace, CVs are evolving into a core facet of the market’s liquidity infrastructure.

“The GP-led market is really the tip of the spear in catalyzing how companies stay private longer, how shareholders move in and out of private companies, and how economics transfer within ownership structures,” DiGeronimo said.

A chart showing the number of announced continuation vehicle transactions annually in North America from 2021 to YTD 2026 as of 10 November.Source: Mergermarket, data correct as at 10 Nov 2026

Beyond trophy assets 

Moreover, the single-asset CV opportunity set is also expanding.

In recent years, the consensus view has been that CVs are best reserved for so-called “trophy assets” – those companies GPs want to retain for another bite at the apple, while simultaneously providing a liquidity route for LPs.

But that is changing too.

One investor source at a buyout shop that runs a dedicated GP-led secondary strategy noted that his firm had initially expected to find only “trophy assets.” It has since realized that GPs are increasingly looking at CVs for a greater variety of assets.

Some investors say that the uptick in deal flow means they must be more discerning than previously.

“Market activity continues to accelerate to record highs but it’s now a much broader set of varying quality companies and diverging deal motivations,” Christophe Browne, a partner at Lexington Partners, said at the recent Mergermarket Private Equity Forum US, noting that CVs were once described as only for the “greatest hits” of private equity.

“You better have the experience, the pattern recognition and the skillset to sift through all of that and to identify the best investment opportunities,” he said.

One indicator of this is the number of sponsors pivoting to a CV after first testing the M&A waters. One source at a GP that recently closed a CV after pulling a prior sale attempt said that, via the M&A effort, the sponsor had spotted both additional growth avenues and management-level weaknesses it felt would be best addressed under its ownership.

It is hard to quantify the exact volume of such companies that end up in a CV, but Mergermarket has reported on several over the past year. Examples include Audax Private Equity-backed Beacon Mobility, which reached the second round of an auction process in 2024, before a CV was pursued last year.

So-called CV-squared transactions, which involve assets moving from one CV to another, are another flashpoint. Among announced transactions, examples include a EUR 3.6bn (USD 4bn) transaction last year involving PAI Partners-owned ice cream maker Froneri. Other reported examples where such a structure has been considered include NewSpring-backed healthcare IT business Verisma, while European sponsor Astorg is reportedly considering a CV-squared deal for fund administrator IQ-EQ.

Specialization

For some, the greater variance of the asset pool speaks to a broader convergence between the buyout market and a significant chunk of GP-led secondaries. Advisors say many CV processes are starting to resemble M&A, with practices such as vendor due diligence increasingly common.

This is being accentuated by an evolving buyer pool, as traditional buyout firms approach transactions as concentrated private equity investments, rather than the traditional secondaries playbook of seeking diversified exposure.

Leonard Green & Partners, Accel-KKR (AKKR), TPG and Apollo Global Management were among the first buyout players to launch GP-led strategies, while more recent entrants include New Mountain Capital, Warburg Pincus, H.I.G. Capital, and Hg. They are joined by smaller specialists, as well as incumbent players that have launched dedicated GP-led strategies, with the common theme a more targeted strategy that often emphasizes single-asset CVs.

As the opportunity set grows and the boundaries with the buyout world become increasingly blurred, some are even debating where LPs should place single-asset CVs within their allocation buckets, as Mergermarket has reported.

“The fact that it’s called a secondary is a misnomer in many ways,” Christiaan van der Kam, head of secondaries at Schroders Capital, said at the Mergermarket Private Equity Forum US. “I think it’s just a totally new asset class within private equity.”